Home >> Pharmaceuticals >> Food & Beverage >>

Lee's Pharmaceutical Holdings Limited - Product Pipeline Review - 2015

Published: Aug-2015 | Format: PDF | Global Markets Direct | Number of pages: 66 | Code: MRS - 35149

Lee's Pharmaceutical Holdings Limited - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Lee's Pharmaceutical Holdings Limited - Product Pipeline Review - 2015’, provides an overview of the Lee's Pharmaceutical Holdings Limited’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Lee's Pharmaceutical Holdings Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Lee's Pharmaceutical Holdings Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Lee's Pharmaceutical Holdings Limited’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Lee's Pharmaceutical Holdings Limited’s pipeline products

Reasons to buy

- Evaluate Lee's Pharmaceutical Holdings Limited’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Lee's Pharmaceutical Holdings Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Lee's Pharmaceutical Holdings Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Lee's Pharmaceutical Holdings Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Lee's Pharmaceutical Holdings Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Lee's Pharmaceutical Holdings Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 6
Lee's Pharmaceutical Holdings Limited Snapshot 7
Lee's Pharmaceutical Holdings Limited Overview 7
Key Information 7
Key Facts 7
Lee's Pharmaceutical Holdings Limited - Research and Development Overview 8
Key Therapeutic Areas 8
Lee's Pharmaceutical Holdings Limited - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Combination Treatment Modalities 13
Pipeline Products - Partnered Products 14
Partnered Products/Combination Treatment Modalities 15
Lee's Pharmaceutical Holdings Limited - Pipeline Products Glance 16
Lee's Pharmaceutical Holdings Limited - Late Stage Pipeline Products 16
Pre-Registration Products/Combination Treatment Modalities 16
Phase III Products/Combination Treatment Modalities 17
Lee's Pharmaceutical Holdings Limited - Clinical Stage Pipeline Products 18
Phase II Products/Combination Treatment Modalities 18
Phase I Products/Combination Treatment Modalities 19
Lee's Pharmaceutical Holdings Limited - Early Stage Pipeline Products 20
IND/CTA Filed Products/Combination Treatment Modalities 20
Preclinical Products/Combination Treatment Modalities 21
Lee's Pharmaceutical Holdings Limited - Unknown Stage Pipeline Products 22
Unknown Products/Combination Treatment Modalities 22
Lee's Pharmaceutical Holdings Limited - Drug Profiles 23
trazodone hydrochloride 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
prulifloxacin 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
gimatecan 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
istaroxime 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
RGN-259 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
rostafuroxin 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
ZK-001 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
ZK-003 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
ZK-010 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
ZK-011 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
ZK-012 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
ZK-014 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
ZK-016 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
(adapalene + clindamycin hydrochloride) 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
ZK-013 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
LQ-7 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
AK-12 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
STIA-1014 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
ZK-002 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
ZK-004 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
ZK-009 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
ZK-015 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
procarbazine hydrochloride 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
Lee's Pharmaceutical Holdings Limited - Pipeline Analysis 52
Lee's Pharmaceutical Holdings Limited - Pipeline Products by Target 52
Lee's Pharmaceutical Holdings Limited - Pipeline Products by Route of Administration 53
Lee's Pharmaceutical Holdings Limited - Pipeline Products by Molecule Type 54
Lee's Pharmaceutical Holdings Limited - Pipeline Products by Mechanism of Action 55
Lee's Pharmaceutical Holdings Limited - Recent Pipeline Updates 56
Lee's Pharmaceutical Holdings Limited - Dormant Projects 62
Lee's Pharmaceutical Holdings Limited - Discontinued Pipeline Products 63
Discontinued Pipeline Product Profiles 63
gimatecan 63
Lee's Pharmaceutical Holdings Limited - Locations And Subsidiaries 64
Head Office 64
Other Locations & Subsidiaries 64
Appendix 65
Methodology 65
Coverage 65
Secondary Research 65
Primary Research 65
Expert Panel Validation 65
Contact Us 65
Disclaimer 66

List of Tables
Lee's Pharmaceutical Holdings Limited, Key Information 7
Lee's Pharmaceutical Holdings Limited, Key Facts 7
Lee's Pharmaceutical Holdings Limited - Pipeline by Indication, 2015 9
Lee's Pharmaceutical Holdings Limited - Pipeline by Stage of Development, 2015 11
Lee's Pharmaceutical Holdings Limited - Monotherapy Products in Pipeline, 2015 12
Lee's Pharmaceutical Holdings Limited - Combination Treatment Modalities in Pipeline, 2015 13
Lee's Pharmaceutical Holdings Limited - Partnered Products in Pipeline, 2015 14
Lee's Pharmaceutical Holdings Limited - Partnered Products/ Combination Treatment Modalities, 2015 15
Lee's Pharmaceutical Holdings Limited - Pre-Registration, 2015 16
Lee's Pharmaceutical Holdings Limited - Phase III, 2015 17
Lee's Pharmaceutical Holdings Limited - Phase II, 2015 18
Lee's Pharmaceutical Holdings Limited - Phase I, 2015 19
Lee's Pharmaceutical Holdings Limited - IND/CTA Filed, 2015 20
Lee's Pharmaceutical Holdings Limited - Preclinical, 2015 21
Lee's Pharmaceutical Holdings Limited - Unknown, 2015 22
Lee's Pharmaceutical Holdings Limited - Pipeline by Target, 2015 52
Lee's Pharmaceutical Holdings Limited - Pipeline by Route of Administration, 2015 53
Lee's Pharmaceutical Holdings Limited - Pipeline by Molecule Type, 2015 54
Lee's Pharmaceutical Holdings Limited - Pipeline Products by Mechanism of Action, 2015 55
Lee's Pharmaceutical Holdings Limited - Recent Pipeline Updates, 2015 56
Lee's Pharmaceutical Holdings Limited - Dormant Developmental Projects,2015 62
Lee's Pharmaceutical Holdings Limited - Discontinued Pipeline Products, 2015 63
Lee's Pharmaceutical Holdings Limited, Subsidiaries 64

List of Figures
Lee's Pharmaceutical Holdings Limited - Pipeline by Top 10 Indication, 2015 9
Lee's Pharmaceutical Holdings Limited - Pipeline by Stage of Development, 2015 11
Lee's Pharmaceutical Holdings Limited - Monotherapy Products in Pipeline, 2015 12
Lee's Pharmaceutical Holdings Limited - Partnered Products in Pipeline, 2015 14
Lee's Pharmaceutical Holdings Limited - Pipeline by Top 10 Target, 2015 52
Lee's Pharmaceutical Holdings Limited - Pipeline by Top 10 Route of Administration, 2015 53
Lee's Pharmaceutical Holdings Limited - Pipeline by Top 10 Molecule Type, 2015 54
Lee's Pharmaceutical Holdings Limited - Pipeline Products by Top 10 Mechanism of Action, 2015 55

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing